Gunther Birznieks Selected Research

tasimelteon

1/2022	Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon.
12/2021	Tasimelteon safely and effectively improves sleep in Smith-Magenis syndrome: a double-blind randomized trial followed by an open-label extension.
1/2020	Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
2/2009	Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gunther Birznieks Research Topics

Disease

3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 02/2009
2	Gastroparesis 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2022
2	Vomiting 01/2021 - 01/2020
2	Nausea 01/2021 - 01/2020
1	Sleep Wake Disorders 01/2022
1	Atopic Dermatitis (Atopic Eczema) 12/2021
1	Smith-Magenis Syndrome 12/2021
1	Sleepiness 01/2020
1	Jet Lag Syndrome 01/2020
1	Motion Sickness (Airsickness) 01/2020
1	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 02/2009

Drug/Important Bio-Agent (IBA)

4	tasimelteonIBA 01/2022 - 02/2009
2	MelatoninIBA 01/2022 - 02/2009
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2022
1	motilin receptorIBA 01/2022
1	apilimodIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 12/2021
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2021
1	EmeticsIBA 01/2020
1	Substance PIBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2020